Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies - Authors’ reply

doi:10.1016/j.jad.2020.05.154

UM > Faculty of Health Sciences

Residential College	false
Status	已發表Published
	Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies - Authors’ reply
	Zheng, Wei 1; Sim, Kang 2; Ning, Yu Ping 1,3; Xiang, Yu Tao4,5
	2020-09-01
Source Publication	Journal of Affective Disorders
ISSN	0165-0327
Volume	274
DOI	10.1016/j.jad.2020.05.154
URL	View the original
Language	英語English
WOS ID	WOS:000556600700013
Scopus ID	2-s2.0-85086106259
Fulltext Access	View Full-Text via DOI View Full-Text via Web of Science View Full-Text via Scopus
Citation statistics
Document Type	Journal article
Collection	Faculty of Health Sciences
Corresponding Author	Xiang, Yu Tao
Affiliation	1.The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China 2.West Region, Institute of Mental Health, Buangkok, Buangkok Green Medical Park, Singapore 3.The first School of Clinical Medicine, Southern Medical University, Guangzhou, China 4.Unit of Psychiatry, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, China 5.Center for Cognition and Brain Sciences, University of Macau, Taipa, China
Corresponding Author Affilication	Faculty of Health Sciences; University of Macau
Recommended Citation GB/T 7714	Zheng, Wei,Sim, Kang,Ning, Yu Ping,et al. Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies - Authors’ reply[J]. Journal of Affective Disorders, 2020, 274.
APA	Zheng, Wei., Sim, Kang., Ning, Yu Ping., & Xiang, Yu Tao (2020). Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies - Authors’ reply. Journal of Affective Disorders, 274.
MLA	Zheng, Wei,et al."Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies - Authors’ reply".Journal of Affective Disorders 274(2020).

Files in This Item:
There are no files associated with this item.

If you have any objections to this item, please fill out the form below and the administrator will contact you as soon as possible.
Content:
Email：	*
Affiliation No.
Verification Code:	Refresh

Any comments and suggestions are welcomed.
Title:	*
Content:
Email：	*
Verification Code:	Refresh